A share price of Acrivon Therapeutics Inc [ACRV] is currently trading at $2.28, up 10.14%. An important factor to consider is whether the stock is rising or falling in short-term value. The ACRV shares have gain 12.32% over the last week, with a monthly amount glided 31.03%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 16, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $16 on the stock. Ladenburg Thalmann downgraded its rating to a Neutral. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $14 as its price target on March 01, 2024. In a note dated October 05, 2023, Maxim Group initiated an Buy rating.
Acrivon Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $1.05 and $8.54. Currently, Wall Street analysts expect the stock to reach $21.83 within the next 12 months. Acrivon Therapeutics Inc [NASDAQ: ACRV] shares were valued at $2.28 at the most recent close of the market. An investor can expect a potential return of 857.46% based on the average ACRV price forecast.
Analyzing the ACRV fundamentals
Gross Profit Margin for this corporation currently stands at -1.43% with Operating Profit Margin at -111.33%, Pretax Profit Margin comes in at -101.37%, and Net Profit Margin reading is -101.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.54, Equity is -0.51 and Total Capital is -0.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.09 points at the first support level, and at 1.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.41, and for the 2nd resistance point, it is at 2.53.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Acrivon Therapeutics Inc [NASDAQ:ACRV] is 10.31. On the other hand, the Quick Ratio is 10.31, and the Cash Ratio is 3.12.
Transactions by insiders
Recent insider trading involved PERCEPTIVE ADVISORS LLC, 10% Owner, that happened on Apr 30 ’25 when 0.44 million shares were sold. 10% Owner, PERCEPTIVE ADVISORS LLC completed a deal on May 01 ’25 to sell 0.3 million shares. Meanwhile, 10% Owner PERCEPTIVE ADVISORS LLC sold 1.05 million shares on Apr 25 ’25.
